|
MAP1LC3B2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.136410E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.257980E-02 |
| Normal-vs-Stage2 |
1.134070E-02 |
| Normal-vs-Stage3 |
3.139700E-02 |
| Normal-vs-Stage4 |
3.659800E-01 |
| Stage1-vs-Stage2 |
3.369200E-01 |
| Stage1-vs-Stage3 |
2.367000E-01 |
| Stage1-vs-Stage4 |
9.603400E-01 |
| Stage2-vs-Stage3 |
9.076400E-01 |
| Stage2-vs-Stage4 |
4.785600E-01 |
| Stage3-vs-Stage4 |
5.342400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.236100E-03 |
| Normal-vs-AfricanAmerican |
5.217300E-03 |
| Normal-vs-Asian |
7.321400E-01 |
| Caucasian-vs-AfricanAmerican |
4.571200E-01 |
| Caucasian-vs-Asian |
6.656800E-01 |
| AfricanAmerican-vs-Asian |
5.230000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.344400E-03 |
| Normal-vs-Female |
5.523500E-03 |
| Male-vs-Female |
7.424800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.607200E-01 |
| Normal-vs-Extreme_Weight |
3.068000E-02 |
| Normal-vs-Obese |
7.803500E-04 |
| Normal-vs-Extreme_Obese |
5.788000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.032800E-01 |
| Normal_Weight-vs-Obese |
4.041500E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.159000E-01 |
| Extreme_Weight-vs-Obese |
9.729800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.454600E-01 |
| Obese-vs-Extreme_Obese |
3.676200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.563800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.990400E-04 |
| Normal-vs-Age(61-80Yrs) |
4.015700E-02 |
| Normal-vs-Age(81-100Yrs) |
8.003200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.766200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.620400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.028100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.056300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.673600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.205200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.632130E-04 |
| Normal-VS-Type2 PRCC |
2.225600E-01 |
| Normal-VS-KIRP CIMP |
9.339300E-03 |
| Normal-VS-Unclassified PRCC |
2.168100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.143600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.658300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.445600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.756800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.740800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.502220E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.886160E-01 |
| Normal-vs-N1 |
9.547500E-02 |
| Normal-vs-N2 |
6.728000E-01 |
| N0-vs-N1 |
5.985200E-01 |
| N0-vs-N2 |
5.194800E-01 |
| N1-vs-N2 |
3.310200E-01 |
|
|
